TMRW Life Sciences, Inc.

TMRW Life Sciences manufactures and operates the world's first FDA-cleared automated platform for specimen management and cryogenic storage of frozen eggs and embryos. The company serves fertility clinics with an integrated digital ecosystem comprising RFID-tracked inventory management, ivfOS software database, 24/7 monitoring via Overwatch®, and flexible storage configurations (onsite/offsite, liquid/vapor phase nitrogen). TMRW's core offering includes automated storage systems (robots and vault solutions), specimen transport with GPS tracking, digital chain-of-custody documentation, and a biorepository service for patients. The platform is designed by embryologists and addresses legacy dewar-based specimen management by consolidating inventory control, reducing operational footprint, and minimizing points of failure by up to 94%. Regulatory credentials include FDA clearance, CE marking, and HIPAA-compliant data security. Target market is fertility clinics ranging from single-site practices to multi-clinic networks. The company emphasizes reduced cryoroom footprint, digitized legacy inventory systems, and real-time specimen visibility. Services include clinic support, patient biorepository options, and ongoing platform monitoring.